Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Yinao Jieyu Granules for depression (kidney deficiency and liver stagnation pattern)
CTR20252618Phase 3Active
- Sponsor
- Zhongjing Wanxi Pharmaceutical
- Start
- Jul 2025
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Kaixin Changyu Granule in major depressive disorder (MDD), sponsored by Zhongjing Wanxi Pharmaceutical. Started Jul 2025; status: active.
02
Drugs
Kaixin Changyu Granule
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20252618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252618.